Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients

NCT01019551 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: ART Intensification
BIOLOGICAL: Immunomodulation

Sponsor

Objectif Recherche Vaccins SIDA

Collaborators

[object Object]
[object Object]
[object Object]